(Q36534686)
Statements
1 reference
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study (English)
1 reference
Marek Jasiówka
1 reference
Matthew J Ellis
1 reference
Antonio Llombart-Cussac
1 reference
David Feltl
1 reference
John A Dewar
1 reference
Nicola Hewson
1 reference
Yuri Rukazenkov
1 reference
John F R Robertson
1 reference
14 September 2015
1 reference
1 reference
3781-3787
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference